WO2022018642 - CAROTENOID FORMULATION FOR INCREASED BIOAVAILABILITY

National phase entry:
Publication Number WO/2022/018642
Publication Date 27.01.2022
International Application No. PCT/IB2021/056562
International Filing Date 20.07.2021
Title **
[English] CAROTENOID FORMULATION FOR INCREASED BIOAVAILABILITY
[French] FORMULATION DE CAROTÉNOÏDE POUR UNE BIODISPONIBILITÉ ACCRUE
Applicants **
INDUSTRIAL ORGANICA, SA DE CV Ave. Almazan #100, Col. Topo Chico Monterrey, N.L., 64260, MX
Inventors
NOLAN, John Penbea House, 2 CNOC An Oir, Williamstown Road Waterford, X91FR8K, IE
PRADO-CABRERO, Alfonso 54 Oaks Avenue, Carraig an Aird Six Cross Roads, X91RXY9, IE
GREEN, Marina Talbot Place Tramore Waterford, X91R2W4, IE
TORRES QUIROGA, Jose Ave. Almazan No. 100, Col. Topo Chico Monterrey, N.L., 64260, MX
TORRES GOMEZ, Carlos Ave. Almazan No. 100, Col. Topo Chica Monterrey, N.L., 64260, MX
MARQUEZ SANTACRUZ, Jazmin Sauces #122 Col. Pedregal de San Agustin 3er Sector, CP General Escobedo, N.L., 66068, MX
Priority Data
63/054,653   21.07.2020   US
17/377,092   15.07.2021   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1477
EPO Filing, Examination6972
Japan Filing595
South Korea Filing607
USA Filing, Examination3510
MasterCard Visa

Total: 13161

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] A composition including a xanthophyll carotenoid diacetate, a transition metal salt, and phospholipids is provided. The composition does not include micelles and is not an emulsion. Methods of supporting eye health in subjects in need thereof using the composition are also provided.[French] L'invention concerne une composition comprenant un diacétate de caroténoïde de xanthophylle, un sel de métal de transition et des phospholipides. La composition ne comprend pas de micelles et n'est pas une émulsion. L'invention concerne également des procédés d'amélioration de la santé oculaire chez des sujets en ayant besoin à l'aide de la composition.
An unhandled error has occurred. Reload 🗙